TD-4208

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2013-2017
01220132017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Revefenacin (TD-4208) is a novel, long-acting, and lung-selective muscarinic cholinergic receptor (mAChR) antagonist in… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2018
2018
BACKGROUND Revefenacin (TD-4208) is a potent, lung-selective, long-acting muscarinic antagonist currently in development as a… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Review
2017
Review
2017
INTRODUCTION Long acting muscarinic receptor antagonists (LAMA) reverse airflow obstruction by antagonizing para-sympathetic… (More)
Is this relevant?
2013
2013
Tiotropium is currently the only once-daily, long-acting muscarinic antagonist (LAMA) approved in the United States and other… (More)
  • figure 2
  • table 1
  • figure 3
  • table 2
  • figure 4
Is this relevant?
Review
2013
Review
2013
The use of muscarinic receptor antagonists in the treatment of chronic obstructive pulmonary disease (COPD) is well established… (More)
Is this relevant?